SYRE vs MATX

Comparison between Spyre Therapeutics Inc (SYRE, Company) and Matson Inc (MATX, Company).

SYRE is from the Healthcare sector, while MATX is from the Industrials sector.

5-Year PerformanceMATX has outperformed SYRE, delivering a return of +27.2% compared to -13.3%

SYRE vs MATX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	SYRE(COMPANY)	MATX(COMPANY)
Market Cap	$5.92B	$5.88B
Max Drawdown	99.11%	72.14%
Sharpe Ratio	2.48	1.68
5Y Beta	1.78	1.07
Industry	Biotechnology	Marine Shipping
P/E Ratio	-30.42	17.13
Forward P/E	N/A	19.19
PEG Ratio	N/A	2.01
Dividend Yield	N/A	0.71%
5Y Dividends CAGR	N/A	14.11%
5Y EPS CAGR	-2.15%	35.64%
Debt to Equity	0.00%	12.52%
Free Cash Flow Yield	-3.14%	9.39%
P/S Ratio	650.22	1.81
P/B Ratio	12.66	2.14

Market Cap

Winner

SYRE

$5.92B

MATX

$5.88B

Max Drawdown

SYRE

99.11%

Winner

MATX

72.14%

Sharpe Ratio

Winner

SYRE

2.48

MATX

1.68

5Y Beta

SYRE

1.78

Winner

MATX

1.07

Industry

SYRE

Biotechnology

MATX

Marine Shipping

P/E Ratio

Winner

SYRE

-30.42

MATX

17.13

Forward P/E

SYRE

N/A

MATX

19.19

PEG Ratio

SYRE

N/A

MATX

2.01

Dividend Yield

SYRE

N/A

MATX

0.71%

5Y Dividends CAGR

SYRE

N/A

MATX

14.11%

5Y EPS CAGR

SYRE

-2.15%

Winner

MATX

35.64%

Debt to Equity

Winner

SYRE

0.00%

MATX

12.52%

Free Cash Flow Yield

SYRE

-3.14%

Winner

MATX

9.39%

P/S Ratio

SYRE

650.22

Winner

MATX

1.81

P/B Ratio

SYRE

12.66

Winner

MATX

2.14

SYRE vs MATX - Historical Returns

Returns include dividend reinvestment.

Period	SYRE	MATX
1 month	+7.66%	+12.74%
3 months	+99.93%	+35.50%
6 months	+140.30%	+69.76%
1 year	+356.18%	+78.04%
5 years(CAGR)	-13.30%	+27.17%
10 years(CAGR)	-6.27%	+21.90%
Max(CAGR)	-10.30%	+10.25%

SYRE

+7.66%

Winner

MATX

+12.74%

Winner

SYRE

+99.93%

MATX

+35.50%

Winner

SYRE

+140.30%

MATX

+69.76%

Winner

SYRE

+356.18%

MATX

+78.04%

5Y(CAGR)

SYRE

-13.30%

Winner

MATX

+27.17%

10Y(CAGR)

SYRE

-6.27%

Winner

MATX

+21.90%

Max(CAGR)

SYRE

-10.30%

Winner

MATX

+10.25%

SYRE vs MATX - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	SYRE	MATX
2026	+164.19%	+63.83%
2025	+37.36%	-9.23%
2024	+8.79%	+20.73%
2023	+104.27%	+78.24%
2022	-90.57%	-28.82%
2021	-44.51%	+61.12%
2020	+1.55%	+44.76%
2019	-4.98%	+29.42%
2018	+39.22%	+6.17%
2017	+18.38%	-15.19%
2016	-55.48%	-11.72%
2015	N/A	+27.00%
2014	N/A	+36.22%
2013	N/A	+5.31%
2012	N/A	-38.68%
2011	N/A	+0.21%
2010	N/A	+18.02%
2009	N/A	+38.23%
2008	N/A	-49.48%
2007	N/A	+16.44%
2006	N/A	-17.03%
2005	N/A	+29.32%
2004	N/A	+27.30%
2003	N/A	+30.11%
2002	N/A	+1.48%
2001	N/A	+6.35%
2000	N/A	+25.12%
1999	N/A	-3.77%

SYRE vs MATX Drawdown Comparison

The maximum drawdown for SYRE was -99.11%, occurring on Jun 21, 2023. This drawdown has not yet recovered.

The maximum drawdown for MATX was -71.41%, occurring on Mar 6, 2009. Recovery took 2091 trading sessions.

The current SYRE drawdown is -73.05%.

Rank	SYRE	MATX
#1	-99.11% Apr 8, 2016 - Jun 21, 2023	-71.41% Jul 19, 2007 - Nov 5, 2015
#2	N/A	-55.15% Nov 6, 2015 - Oct 9, 2020
#3	N/A	-53.61% Mar 29, 2022 - Jan 22, 2024
#4	N/A	-46.91% Nov 13, 2024 - Feb 2, 2026
#5	N/A	-27.99% May 23, 2002 - Jul 30, 2003
#6	N/A	-27.81% Jan 10, 2001 - Apr 16, 2002
#7	N/A	-27.79% Dec 22, 2005 - Apr 20, 2007
#8	N/A	-22.77% Nov 3, 1999 - Jun 1, 2000
#9	N/A	-22.23% Mar 11, 2021 - Aug 25, 2021
#10	N/A	-19.62% Jan 27, 2005 - Jul 1, 2005
#11	N/A	-17.29% Aug 11, 2000 - Nov 17, 2000
#12	N/A	-16.67% Jul 22, 2005 - Dec 21, 2005
#13	N/A	-16.23% Nov 12, 2021 - Jan 26, 2022
#14	N/A	-16.20% Feb 15, 2024 - May 28, 2024
#15	N/A	-14.97% Mar 1, 2004 - Oct 1, 2004

Correlation

Correlation between SYRE and MATX is -0.67 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.67

-101